Picroside II attenuates fatty acid accumulation in HepG2 cells via modulation of fatty acid uptake and synthesis

BACKGROUND/AIMS: Hepatic steatosis is caused by an imbalance between free fatty acids (FFAs) uptake, utilization, storage, and disposal. Understanding the molecular mechanisms involved in FFAs accumulation and its modulation could drive the development of potential therapies for Nonalcoholic fatty liver disease. The aim of the current study was to explore the effects of picroside II, a phytoactive found in Picrorhiza kurroa, on fatty acid accumulation vis-à-vis silibinin, a known hepatoprotective phytoactive from Silybum marianum. METHODS: HepG2 cells were loaded with FFAs (oleic acid:palmitic acid/2:1) for 20 hours to mimic hepatic steatosis. The FFAs concentration achieving maximum fat accumulation and minimal cytotoxicity (500 μM) was standardized. HepG2 cells were exposed to the standardized FFAs concentration with and without picroside II pretreatment. RESULTS: Picroside II pretreatment inhibited FFAs-induced lipid accumulation by attenuating the expression of fatty acid transport protein 5, sterol regulatory element binding protein 1 and stearoyl CoA desaturase. Preatreatment with picroside II was also found to decrease the expression of forkhead box protein O1 and phosphoenolpyruvate carboxykinase. CONCLUSIONS: These findings suggest that picroside II effectively attenuated fatty acid accumulation by decreasing FFAs uptake and lipogenesis. Picroside II also decreased the expression of gluconeogenic genes.

Polimorfismo Ala54Thr do gene fatty acid-binding protein-2 (FABP-2): uma revisão bibliográfica / The Ala54Thr polymorphism of the fatty acid-binding protein-2 (FABP-2) gene: a literature review

O polimorfismo p.Ala54Thr (rs1799883) do gene fatty acid-binding protein-2 (FABP2) tem associação com resistência insulínica, síndrome metabólica e obesidade. A hipótese é de que o alelo mutante aumente a absorção de ácidos graxos intestinais, a concentração lipídica plasmática e a oxidação de gordura. Assim, o objetivo deste trabalho foi revisar o papel do polimorfismo p.Ala54Thr do gene FABP-2 na obesidade. A busca da literatura foi realizada na base de dados MEDLINE, através do PubMed e no Portal de Periódicos de Aperfeiçoamento de Pessoal de Nível Superior (Capes) com termos relacionados com o polimorfismo e obesidade. Parece não haver uma associação significativa da presença do alelo Thr54 com obesidade, apesar de ser uma doença complexa e que possivelmente não tenha sido captada por estudos de associação; diferente do colesterol total e lipoproteína de baixa densidade (low density level cholesterol, LDL-c), maior nos portadores do alelo Thr54. Alterações de adipocitocinas devem estar associadas a estas diferenças de perfil lipídico.

The p.Ala54Thr polymorphism (rs1799883) of the fatty acid-binding Protein-2 (FABP-2) gene has been associated with insulin resistance, metabolic syndrome and obesity. The hypothesis that the mutant allele increases the absorption of fatty acid by the bowel, plasma lipid concentration, and fat oxidation. Thus, the aim of this study was to review the role of FABP-2 Ala54Thr polymorphism in obesity. A literature search was conducted in MEDLINE database, using PubMed and Capes Portal with terms related to polymorphism and obesity. It does not seem to be a significant association between Thr54 allele and obesity, although being a complex disease and that possibly has not been captured by association studies; unlike total cholesterol and low density level cholesterol (LDL-c), which were higher in Thr54 allele carriers. Adipocytokines changes should be associated with these differences in lipid profile.

Análisis estructural y funcional de proteínas solubles que unen lípidos de intestino e hígado / Structure-function analysis of soluble lipid binding proteins from intestine and liver / Análise estrutural e funcional de proteínas solúveis que ligam lipídeos de intestino e fígado

Luego de la ingesta, el epitelio del intestino delgado está encargado de asimilar grandes cantidades de nutrientes, como aminoácidos, glúcidos y ácidos grasos. Las proteínas solubles que unen lípidos cumplirían un rol determinante en este proceso, sobre todo protegiendo la integridad del tejido contra el efecto simil-detergente de los ácidos grasos provenientes de la dieta. En enterocitos se expresan dos proteínas que unen ácidos grasos de cadena larga, IFABP y LFABP, para las cuales no se conocen bien aún sus funciones específicas, o el porqué de la necesidad de dos proteínas aparentemente equivalentes. Este laboratorio se ha enfocado en el estudio comparativo de estas dos proteínas empleando distintas variantes estructurales y métodos bioquímicos, biofísicos, y de biología molecular y celular. Así, se han podido definir los determinantes moleculares de cada proteína responsables de la interacción con membranas, los mecanismos de transferencia de ligandos y los factores que modulan estas propiedades. Más recientemente, se han extendido estos ensayos a cultivos celulares donde se ha correlacionado la expresión de estas proteínas con la secreción de citoquinas, la proliferación y la diferenciación celular. El estudio de estas proteínas es de gran importancia por su potencial como blancos terapéuticos y su utilidad en el diagnóstico de injurias tisulares.

After ingestion, the epithelium of the small intestine is responsible for assimilating large amounts of nutrients such as amino acids, sugars and fatty acids. Soluble lipid binding proteins fulfill a determining role in this process, especially protecting the tissue integrity against the detergent-like effect of fatty acids from the diet. Two proteins that bind long-chain fatty acids are expressed in enterocytes, IFABP and LFABP, whose specific functions are still poorly understood, or the reason for the need of two apparently equivalent proteins. Our laboratory has focused on the comparative study of these two proteins using structural variants and biochemical, biophysical, and molecular and cellular biology approaches. Thus, the molecular determinants responsible for the interaction with membranes were defined for each protein, their ligand transfer mechanism and the factors that modulate these properties. More recently, these assays have been extended to cell culture studies which correlate the expression of these proteins with cytokine secretion, cell proliferation and differentiation. The study of these proteins is of great importance due to their potential as therapeutic targets and their usefulness in the diagnosis of tissue injury.

Após a ingestão, o epitélio do intestino delgado é responsável pela assimilação de uma grande quantidade de nutrientes, tais como aminoácidos, glicídios e ácidos graxos. As proteínas solúveis que ligam lipídeos desempenhariam um papel determinante neste processo, principalmente protegendo a integridade do tecido contra o efeito detergente dos ácidos graxos da dieta. Nos enterócitos se expressam duas proteínas que ligam ácidos graxos de cadeia longa, IFABP e LFABP; cujas funções específicas ainda não são muito conhecidas, ou não se conhece o motivo pelo qual são necessárias duas proteínas aparentemente equivalentes. Nosso laboratório tem se focado no estudo comparativo destas duas proteínas utilizando variantes estruturais e métodos bioquímicos, biofísicos, e de biologia molecular e celular. Assim, foi possível definir os determinantes moleculares de cada proteína responsáveis pela interação com membranas, os mecanismos da transferência de ligantes e os fatores que modulam essas propriedades. Mais recentemente, estendemos estes ensaios para culturas celulares, correlacionando a expressão destas proteínas com a secreção de citocinas, a proliferação e a diferenciação celular. O estudo destas proteínas é de grande importância por seu potencial como alvos terapêuticos e sua utilidade no diagnóstico de lesões teciduais.

Evaluation of local immune response to Fasciola hepatica experimental infection in the liver and hepatic lymph nodes of goats immunized with Sm14 vaccine antigen

Protection against Fasciola hepatica in goats immunized with a synthetic recombinant antigen from Schistosoma mansoni fatty acid-binding protein 14 (rSm14) was investigated by assessing worm burdens, serum levels of hepatic enzymes, faecal egg count and hepatic damage, which was evaluated using gross and microscopic morphometric observation. The nature of the local immune response was assessed by examining the distribution of CD2+, CD4+, CD8+ and γ´+ T lymphocytes along with IgG+, IL-4+ and IFN-γ+ cells in the liver and hepatic lymph nodes (HLN). The goats used consisted of group 1 (unimmunized and uninfected), group 2 [infected control - immunized with Quillaia A (Quil A)] and group 3 (immunized with rSm14 in Quil A and infected), each containing seven animals. Immunization with rSm14 in Quil A adjuvant induced a reduction in gross hepatic lesions of 56.6 percent (p < 0.001) and reduced hepatic and HLN infiltration of CD2+, CD4+, CD8+ and γ´+ T lymphocytes as well as IL-4+ and IFN-γ+ cells (p < 0.05). This is the first report of caprine immunization against F. hepatica using a complete rSm14 molecule derived from S. mansoni. Immunization reduced hepatic damage and local inflammatory infiltration into the liver and HLN. However, considering that Quil A is not the preferential/first choice adjuvant for Sm14 immunization, further studies will be undertaken using the monophosphoryl lipid A-based family of adjuvants during clinical trials to facilitate anti-Fasciolavaccine development.

Diagnóstico in vitro de la deficiencia primaria de carnitina / In vitro diagnosis of primary carnitine deficiency

El transportador de carnitina (OCTN2) es fundamental para el metabolismo mitocondrial de los ácidos grasos de cadena larga. Su carencia produce la deficiencia primaria de carnitina. El presente estudio tuvo como objetivo el análisis de los ácidos grasos producidos por fibroblastos incubados en presencia de sustratos deuterados, mediante cromatografía de gases acoplada a espectrometría de masas (GC - MS) como herramienta diagnóstica de la deficiencia primaria de carnitina. Se encontró un perfil característico en esta deficiencia, lo que permite su diagnóstico in vitro.

Carnitine transporter (OCTN2) is required for the mitochondrial metabolism of long-chain fatty acids. Primary carnitine deficiency is a consequence of its deficiency. The objective of the present study was to analyse the fatty acids produced by fibroblasts incubated with deuterated substrates, using gas chromatography-mass spectrometry as a diagnostic tool for the diagnosis of VLCAD deficiency. A characteristic profile for this deficiency was found using this technique which enables its in vitro diagnosis.

The expression and the significance of L-FABP and FATP4 in the development of nonalcoholic fatty liver disease in rats / 中华肝脏病杂志

<p><b>OBJECTIVE</b>To study the effect of liver fatty acid binding protein(L-FABP) and fatty acid transport protein (FATP4) in the development of nonalcoholic fatty liver disease (NAFLD) in rats.</p><p><b>METHODS</b>The expression of L-FABP and FATP4 genes was examined in fatty liver rats by reverse transcription and polymerase chain reaction amplification and Western blot methods.</p><p><b>RESULTS</b>In the high fat diet group (F), mRNA and protein expression of L-FABP and FATP4 were increased at 2 weeks, and they increased remarkably at 12 weeks (P < 0.05; L-FABP mRNA F=124.9, protein expression F=92.6; FATP4 mRNA F=602.9, protein expression F=108.8).</p><p><b>CONCLUSION</b>The high expression of L-FABP and FATP4 at the early stage is an adaptive reaction of the body, With the advanced expression of the L-FABP and FATP4, it can lead to a fatty acid disequilibrium and then result in nonalcoholic fatty liver disease in the rats.</p>

Fetal growth and development: roles of fatty acid transport proteins and nuclear transcription factors in human placenta.

In the feto-placental unit, preferential transport of maternal plasma arachidonic acid (20:4n-6) and docosahexaenoic acid (22:5n-3) across the placenta is of critical importance for fetal growth and development. More than 90 per cent of the fat deposition in the fetus occurs in the last 10 weeks of pregnancy. All of the n -3 and n -6 fatty acid structures acquired by the fetus have to cross the placenta and fetal blood are enriched in long chain polyunsaturated fatty acids (LCPUFA) relative to the maternal supply. Fatty acids cross the placental microvillous and basal membranes by simple diffusion and via the action of membrane bound (FAT, FATP and p-FABPpm) and cytoplasmic fatty acid-binding proteins (FABPs). The direction and magnitude of fatty acid flux is mainly dictated by the relative abundance of available binding sites. The existence of a fatty-acid-transport system comprising multiple binding proteins in human placenta may be essential to facilitate the preferential transport of maternal plasma fatty acids in order to meet the requirements of the growing fetus. The critical importance of long-chain fatty acids in cellular homeostasis demands an efficient uptake system for these fatty acids and their metabolism in tissues. In fact, involvement of several nuclear transcription factors (PPARgamma, LXR, RXR, and SREBP-1) is critical in the expression of genes responsible for fatty acids uptake, placental trophoblast differentiation and hCG production. These indicate that these receptors are potential regulators of placental lipid transfer and homeostasis. This review discusses importance of nuclear receptors and fatty acid binding/transport proteins in placental fatty acid uptake, transport and metabolism.